About
Motif Neurotech is a Houston-based company founded in 2022 that develops therapeutic brain-computer interface (BCI) devices aimed at treating mental health conditions, particularly treatment-resistant depression (TRD). The company specializes in creating miniature implantable medical devices that monitor and regulate brain activity, helping patients manage their mental health and cognitive performance. The flagship product, DOT, is a cosmetically invisible brain implant designed to rebalance brain activity in patients with TRD. It is delivered through an outpatient procedure, allowing patients to monitor and regulate their mental states from home. Motif Neurotech's technology utilizes bioelectronics to measure and modulate brain networks, providing an alternative for those who do not respond to traditional pharmaceutical treatments. The company is actively conducting clinical trials to validate the safety and efficacy of its devices. Motif Neurotech aims to support patients suffering from mental health disorders and healthcare providers seeking advanced therapeutic options. The leadership team combines expertise in brain-computer interfaces and neurosurgery to drive innovation in mental health care solutions.
Technologies
Keywords
Company Information
-
Employees 31
-
Founded 2022
-
Annual Revenue $1100000
-
Total Funding $18850000
Location
Houston, Texas, United States, 77006
